Intramedullary spinal metastasis

Intramedullary spinal metastases are rare, occurring in 0.9-2.1~1% of autopsied cancer patients ². They represent 8.5% of central nervous system metastases⁴ and and account for 5% of all intramedullary lesions ³. They are less common than leptomeningeal metastases³.

Intramedullary lesions may result from:

• growth along the Virchow-Robin spaces
• haematogenous dissemination
• direct extension from leptomeninges

Epidemiology

Demographics of affected patients reflect those of the underlying primary malignancy but over all the mean age of presentation is 55 years ⁷. 

Lung cancer accounts for approximately 50% of cases ⁸. Other primary malignancies are breast carcinoma, lymphoma, leukaemia, melanoma, renal cell carcinoma and colorectal carcinoma.

One-third of patients have concomitant brain metastasis and 25% have leptomeningeal metastases ⁵.

Clinical presentation

Intramedullary spinal cord metastasis most commonly occurs in the setting of advanced disease and only rarely is the first presentation of malignancy ⁷.

In contrast to the long duration of symptoms that are typical of primary intramedullary spinal neoplasms, up to 75% of patients with a spinal cord metastasis have symptoms for less than one month before diagnosis ².

The most common presenting symptom is motor weakness. Other common presenting features are pain, bowel or bladder dysfunction, paraesthesia or a rapid decline in neurological status in elderly patients ².

Pathology

Lung cancer accounts for ~50% of cases ⁸. Other primary malignancies are breast cancer, lymphoma, leukaemia, malignant melanoma, renal cell cancer and colorectal cancer.

One-third of patients have concomitant cerebral metastasis and 25% have leptomeningeal metastases⁵.

Radiographic features

The most commonly involved location is the cervical cord, followed by the thoracic cord and then the lumbar cord.

Lesions Lesions are usually solitary and involve 2-3 vertebral body segments.

Plain film

Usually normal.

Myelography/ CT/CT myelography

Usually normal ⁶ although focal expansion or nodularity may be visible.

CT (contrast enhanced)

Hypervascular metastases may rarely be seen as enhancing intraspinal lesions

MRI

Lesions are usually well-defined⁴ and typically produce cord expansion over several segments. In contrast to primary intramedullary neoplasms, associated cysts are rare.

Typical Typical MRI signal characteristics are:

• T1: hypointense
• T2
  • hyperintense
  • prominent oedema commonly surrounds the tumour nodule
• T1 C+ (Gd): avid homogeneous enhancement

Treatment and prognosis

Management of intramedullary metastases generally consists of fractionated radiotherapy, which usually maintains but does not improve the pretreatment level of neurologic function. As with the treatment of brain metastases and epidural spinal cord compression, corticosteroids are used to diminish the effects of radiation-induced edema ⁸.

Intramedullary metastases are associated with a poor prognosis. Up to two thirds of patients die within six months of diagnosis ².

Differential diagnosis

General differential considerations include:

• other intramedullary spinal tumours, for example
  • ependymoma
  • astrocytoma
  • haemangioblastoma
  • etc...
• inflammatory lesions/transverse myelitis
  • usually longer length of cord involvement
  • variable contrast enhancement
  • rapidly progressive clinical course
• multiple sclerosis
  • may not demonstrate enhancement
  • less prominent cord expansion
  • less prominent perilesional oedema
  • lesions are usually multiple
• syrinx
  • central cystic lesion
  • no contrast enhancement

See also

• vertebral metastases
• leptomeningeal spinal metastases